Impact and Utilization of Workflow-Integrated Artificial Intelligence for Remote Patient Monitoring Enrollment

Overview

Información sobre este estudio

The purpose of this study is to evaluate the effectiveness of the RPM AI-guided screening tool (an RPM (remote patient monitoring)  “fit” score as displayed in the Acute Multipatient Viewer (AMP) and underlying AI models in determining patients who may be best impacted by RPM as determined by their total healthcare utilization (total days alive at home, emergency department visits, and hospitalizations). Secondary objectives include assessing whether the algorithm improves the patient identification and enrollment into RPM within routine clinical practice. Additionally, this study will assess usability of this approach and its overall effect on nursing efficiency/workflow and clinician perspective on trust of AI tools to identify patients.

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria:

  • The study participants will be nurses who are part of the RPM care team that cares for adult patients ≥ 18 years.
  • A patient’s data will be included in the analysis if the patient is ≥ 18 years old and receives care from a participating nurse.
  • Patient data will only be collected if permitted (based on the use of the Minnesota Research Authorization Retrieval Tool).
  • Patients who will be considered for this study will be assessed based on standard RPM program inclusion and exclusion criteria for the any of the chronic disease RPM programs (congestive heart failure, coronary artery disease, hypertension, type 2 diabetes, COPD, and general complex care).

Exclusion Criteria: 

  • < 18 years old. 

Eligibility last updated 8/1/22. Questions regarding updates should be directed to the study team contact.

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus Contacto

Rochester, Minn.

Investigador principal de Mayo Clinic

Tufia Haddad, M.D.

Abierto para la inscripción

Contact information:

Julianne Lunde M.A.

(507) 266-2657

Lunde.Julianne@mayo.edu

More information

Publicaciones

Publications are currently not available